File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1161/HYPERTENSIONAHA.113.03051
- Scopus: eid_2-s2.0-84907598477
- WOS: WOS:000340929900019
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Prostaglandin I2 and Prostaglandin E2 Modulate Human Intrarenal Artery Contractility Through Prostaglandin E2-EP4, Prostacyclin-IP, and Thromboxane A2-TP Receptors.
Title | Prostaglandin I2 and Prostaglandin E2 Modulate Human Intrarenal Artery Contractility Through Prostaglandin E2-EP4, Prostacyclin-IP, and Thromboxane A2-TP Receptors. |
---|---|
Authors | |
Keywords | Epoprostenol Kidney Norepinephrine Prostaglandin-endoperoxide synthases |
Issue Date | 2014 |
Citation | Hypertension, 2014, v. 64, p. 551-556 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/203295 |
ISSN | 2023 Impact Factor: 6.9 2023 SCImago Journal Rankings: 2.827 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Eskildsen, MP | en_US |
dc.contributor.author | Hansen, PBL | en_US |
dc.contributor.author | Stubbe, J | en_US |
dc.contributor.author | Toft, A | en_US |
dc.contributor.author | Walter, S | en_US |
dc.contributor.author | Marcussen, N | en_US |
dc.contributor.author | Rasmussen, LM | en_US |
dc.contributor.author | Vanhoutte, PMGR | en_US |
dc.contributor.author | Jensen, BL | en_US |
dc.date.accessioned | 2014-09-19T13:56:11Z | - |
dc.date.available | 2014-09-19T13:56:11Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.citation | Hypertension, 2014, v. 64, p. 551-556 | en_US |
dc.identifier.issn | 0194-911X | - |
dc.identifier.uri | http://hdl.handle.net/10722/203295 | - |
dc.language | eng | en_US |
dc.relation.ispartof | Hypertension | en_US |
dc.subject | Epoprostenol | - |
dc.subject | Kidney | - |
dc.subject | Norepinephrine | - |
dc.subject | Prostaglandin-endoperoxide synthases | - |
dc.title | Prostaglandin I2 and Prostaglandin E2 Modulate Human Intrarenal Artery Contractility Through Prostaglandin E2-EP4, Prostacyclin-IP, and Thromboxane A2-TP Receptors. | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PMGR: vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PMGR=rp00238 | en_US |
dc.identifier.doi | 10.1161/HYPERTENSIONAHA.113.03051 | en_US |
dc.identifier.scopus | eid_2-s2.0-84907598477 | - |
dc.identifier.hkuros | 238768 | en_US |
dc.identifier.volume | 64 | en_US |
dc.identifier.spage | 551 | en_US |
dc.identifier.epage | 556 | en_US |
dc.identifier.eissn | 1524-4563 | - |
dc.identifier.isi | WOS:000340929900019 | - |
dc.identifier.issnl | 0194-911X | - |